. "Appendix B: What Will We Learn from the FDA Clinical Trials Process and What Will We Still Want to Know About Immunotherapies and Depot Medications to Treat Drug Dependence?." New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions
Kosten, T.R., and Biegel, D. (2002). Therapeutic vaccines for substance dependence. Expert Review of Vaccines,1(3), 363-371.
Kosten, T.R., and Kleber, H.D. (1984). Strategies to improve compliance with narcotic antagonists. America Journal of Drug and Alcohol Abuse,10(2), 249-266.
Kosten, T.R., and O’Connor, P.G. (2003). Current concepts—management of drug withdrawal. New England Journal of Medicine,348(18), 1786-1795.
Kosten, T.R., Kreek, M.J., Ragunath, J., and Kleber, H.D. (1986). Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts. Biological Psychiatry,21(2), 217-220.
Kosten, T.R., Rosen, M., Bond, J., Settles, M., Roberts, J.S., Shields, J., Jack, L., and Fox, B. (2002). Human therapeutic cocaine vaccine: Safety and immunogenicity. Vaccine,20(7-8), 1196-1204.
Kranzler, H.R. (1995). The pharmacology of alcohol abuse. New York: Springer-Verlag.
Kranzler, H.R. (2000). Pharmacotherapy of alcoholism: Gaps in knowledge and opportunities for research. Alcohol and Alcoholism,35(6), 537-547.
Kranzler, H.R., and Van Kirk, J. (2001). Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis. Alcoholism, Clinical and Experimental Research,25(9), 1335-1341.
Kranzler, H.R., Modesto-Lowe, V., and Nuwayser, E.S. (1998). Sustained-release naltrexone for alcoholism treatment: A preliminary study. Alcoholism, Clinical and Experimental Research,22(5), 1074-1079.
Kranzler, H.R., Armeli, S., Tennen, H., Blomqvist, O., Oncken, C., Petry, N., and Feinn, R. (2003). Targeted naltrexone for early problem drinkers. Journal of Clinical Psychopharmacology,23(3), 294-304.
Lifshitz, M., Gavrilov, V., and Gorodischer, R. (2001). Off-label and unlicensed use of antidotes in paediatric patients. European Journal of Clinical Pharmacology,56(11), 839-841.
McIntyre, J., Conroy, S., Avery, A., Corns, H., and Choonara, I. (2000). Unlicensed and off label prescribing of drugs in general practice. Archives of Disease in Childhood,83(6), 498-501.
Miro, O., Nogue, S., Espinosa, G., To-Figueras, J., and Sanchez, M. (2002). Trends in illicit drug emergencies: The emerging role of gamma-hydroxybutyrate. Journal of Toxicology—Clinical Toxicology,40(2), 129-135.
Morgan, C., and Kosten, T.R. (1990). Potential toxicity of high dose naltrexone in patients with appetitive disorders. In L. Ried (Ed.), Opioids, bulimia, and alcohol abuse and alcoholism (pp. 261-274). New York: Springer-Verlag.
Nasser, S.M., and Ewan, P.W. (2001). Lesson of the week: Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips. British Medical Journal (Clinical Research Edition),322(7302), 1589-1591.
National Institute on Drug Abuse (1998). National survey results on drug use from Monitoring the Future survey. Rockville, MD: National Institute on Drug Abuse.
O’Malley, S.S., Jaffe, A.J., Chang, G., Schottenfeld, R.S., Meyer, R.E., and Rounsaville, B. (1992). Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry,49(11), 894-898.
Oncken, C.A., and Kranzler, H.R. (2003). Pharmacotherapies to enhance smoking cessation during pregnancy. Drug and Alcohol Review,22(2), 191-202.
Oncken, C.A., Pbert, L., Ockene, J.K., Zapka, J., and Stoddard, A. (2000). Nicotine replacement prescription practices of obstetric and pediatric clinicians. Obstetetrics and Gynecology,96(2), 261-265.
Owens, S.M. (1997). Antibodies as pharmacokinetic and metabolic modifiers of neurotoxicity. NIDA Research Monograph,173, 259-272.